Advertisement

Topics

Lannett Co. Company Profile

08:16 EDT 24th September 2018 | BioPortfolio

Lannett Company, Inc manufactures and distributes pharmaceutical products sold under generic names, and historically, has sold them under trade or brand names as well. The Company's general business offices, laboratory, manufacturing, distribution and research and development facilities are located in a 31,000 square foot facility situated on 4.5 acres in northeast Philadelphia, Pennsylvania.

Location

9000 State Road
Philadelphia
PA
19136
United States of America

Contact

Phone: (215) 333-9000
Fax: (215) 333-9004


News Articles [42 Associated News Articles listed on BioPortfolio]

Lannett Co Inc (LCI) Expected to Post Earnings of $0.76 Per Share

Equities research analysts expect Lannett Co Inc to announce earnings per share of $0.76 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Lannett's ea...

$176.30 Million in Sales Expected for Lannett Co Inc (LCI) This Quarter

Wall Street analysts predict that Lannett Co Inc will announce sales of $176.30 million for the current fiscal quarter, according to Zacks Investment Research . Four analysts have made estimates for L...

Lannett downgraded by Moody's after biggest one-day selloff in quarter century

Lannett is constrained by modest revenues that are entirely concentrated in the US, the rating agency says

Lannett acquires 24 generic drugs from Endo International

Lannett Pharmaceuticals has announced that it has acquired 23 approved drug product applications and one pending from a subsidiary of...Read More... The post Lannett acquires 24 generic drugs from End...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lannett Company, Inc. of Class Action Lawsuit and Upcoming Deadline - LCI

NEW YORK, Aug. 31, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lannett Company, Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its...

Zacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Earnings of $0.76 Per Share

Brokerages expect Lannett Company, Inc. to announce earnings per share of $0.76 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Lannett's earnings, w...

Lannett Acquires Portfolio Of Generic Products From Endo International

NewsThe transaction includes 23 approved and one pending drug product applications, primarily oral solutions.

$176.30 Million in Sales Expected for Lannett Company, Inc. (LCI) This Quarter

Wall Street analysts expect Lannett Company, Inc. to report $176.30 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Lannett's ear...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Cocaine hydrochloride [Lannett Company, Inc.]

COCAINE HYDROCHLORIDE Topical Solution CII

Phentermine hydrochloride [STAT RX USA LLC]

PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV

Phentermine hydrochloride [Blenheim Pharmacal, Inc.]

PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV

Phentermine hydrochloride [H.J. Harkins Company, Inc.]

PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV

Phentermine hydrochloride [Lannett Company, Inc.]

PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [0 Results]

None

More Information about "Lannett Co." on BioPortfolio

We have published hundreds of Lannett Co. news stories on BioPortfolio along with dozens of Lannett Co. Clinical Trials and PubMed Articles about Lannett Co. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lannett Co. Companies in our database. You can also find out about relevant Lannett Co. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record